Top

Clinical Neuroradiology

Published in:

01-06-2015 | Original Article

Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns

Authors: O. Kastrup, MD, PhD, M. Schlamann, MD, PhD, C. Moenninghoff, MD, M. Forsting, S. Goericke, MD

Published in: Clinical Neuroradiology | Issue 2/2015

Abstract

Aim

The aim of this study was to describe lesion patterns, distribution, and evolution in posterior reversible encephalopathy syndrome (PRES) in a larger single-center population.

Methods

Scans and follow-up, if available, of 50 patients with PRES between 2002 and 2011 were reviewed retrospectively. Lesion patterns, extent, and signal intensity changes were identified and graded on fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted images. Hemorrhagic changes were identified on T2* or susceptibility-weighted images, and gadolinium enhancement on T1-weighted images was identified if available.

Results

The most frequently affected regions on FLAIR were the frontal lobes in 54 %, occipital lobes in 34.3 %, and parietal lobes in 31.0 % of cases, thus 65.3 % in the posterior regions. Temporal lobes were affected in 10.6 %, the cerebellum in 6.5 %, and basal ganglia in 1.6 %. Division into vascular supply showed involvement in the anterior circulation in 66.5 % and in the posterior circulation in 33.5 % of cases. On diffusion-weighted imaging (DWI), vasogenic edema was observed in 6.9 %, cytotoxic edema in 9.1 %, and both in 2 % of cases. In 31.9 %, there was shine through, and in 15.9 %, there was shine through as well as cytotoxic or vasogenic edema. Topologic distribution on DWI showed affection of the frontal lobes in 43.5 %, occipital lobes in 25.8 %, parietal lobes in 17.7 %, temporal lobes in 11.3 %, and cerebellum in 1.6 %. T2* or susceptibility-weighted images showed spot-like hemosiderin accumulation in 17.2 % of cases. In 23.1 %, enhancement was seen. Follow-up magnetic resonance imaging showed complete resolution in 66.6 % of patients.

Conclusion

The spectrum of imaging findings in PRES is wide. Almost always subcortical and cortical structures are involved. Although posterior changes are prominent in this syndrome, frontal involvement is more frequent than posterior on FLAIR imaging and DWI. On DWI, mixed patterns are not uncommon. Reversibility generally takes place independent of DWI pathology. Hypertension was not a prognostic factor.

Available only for authorised users

Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J. 2001;77:24–8.PubMedCentralPubMedCrossRef

Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol. 2001;24:361–4.PubMedCrossRef

Ahn KJ, Lee JW, Hahn ST, Yang DW, Kim PS, Kim HJ, Kim CC. Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol. 2003;76:916–9.PubMedCrossRef

Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol. 1999;246:339–46.PubMedCrossRef

Idilman R, De Maria N, Kugelmas M, Colantoni A, Van Thiel DH. Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant. Eur J Gastroenterol Hepatol. 1998;10:433–6.PubMedCrossRef

Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc. 1991;23:3173–4.PubMed

Dicuonzo F, Salvati A, Palma M, Lefons V, Lasalandra G, De Leonardis F, Santoro N. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings. J Child Neurol. 2009;24:1013–8.PubMedCrossRef

Kastrup O, Maschke M, Wanke I, Diener HC. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol. 2002;249:1563–6.PubMedCrossRef

Kastrup O, Diener HC. Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus. J Neurol. 1997;244:274–5.PubMedCrossRef

10.

Kastrup O, Diener HC. TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome. J Neurol. 2008;255:452–3.PubMedCrossRef

11.

Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.PubMedCrossRef

12.

Ni J, Zhou LX, Hao HL, Liu Q, Yao M, Li ML, Peng B, Cui LY. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients. J Neuroimaging. 2011;21:219–24.PubMedCrossRef

13.

Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28:1320–7.PubMedCrossRef

14.

McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, Teksam M. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189:904–12.CrossRef

15.

Psychogios MN, Schramm P, Knauth M. [Reversible encephalopathy syndrome, RES or PRES: a case with more W (watershed) than P (posterior)!]. Rofo. 2010;182:76–9.PubMedCrossRef

16.

Kinoshita T, Moritani T, Shrier DA, Hiwatashi A, Wang HZ, Numaguchi Y, Westesson PL. Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: a pictorial essay. Clin Imaging. 2003;27:307–15.PubMedCrossRef

17.

Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol. 2002;23:1038–48.PubMed

18.

Bhagavati S, Choi J. Atypical cases of posterior reversible encephalopathy syndrome. Clinical and MRI features. Cerebrovasc Dis. 2008;26:564–6.PubMedCrossRef

19.

Donmez FY, Basaran C, Kayahan Ulu EM, Yildirim M, Coskun M. MRI features of posterior reversible encephalopathy syndrome in 33 patients. J Neuroimaging. 2010;20:22–8.PubMedCrossRef

20.

Sheth RD, Riggs JE, Bodenstenier JB, Gutierrez AR, Ketonen LM, Ortiz OA. Parietal occipital edema in hypertensive encephalopathy: a pathogenic mechanism. Eur Neurol. 1996;36:25–8.PubMedCrossRef

21.

Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, Gonzalez RG, Koroshetz WJ. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology. 1998;51:1369–76.PubMedCrossRef

22.

Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000;21:1199–206.PubMed

23.

Lamy C, Oppenheim C, Meder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging. 2004;14:89–96.PubMedCrossRef

24.

Striano P, Striano S, Tortora F, De Robertis E, Palumbo D, Elefante A, Servillo G. Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit. 2005;11:CR549–53.

25.

Weingarten K, Barbut D, Filippi C, Zimmerman RD. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol. 1994;162:665–70.CrossRef

26.

Doelken M, Lanz S, Rennert J, Alibek S, Richter G, Doerfler A. Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol. 2007;13:125–8.PubMed

27.

Coughlin WF, McMurdo SK, Reeves T. MR imaging of postpartum cortical blindness. J Comput Assist Tomogr. 1989;13:572–6.PubMedCrossRef

28.

Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke. 1988;19:326–9.PubMedCrossRef

29.

Benziada-Boudour A, Schmitt E, Kremer S, Foscolo S, Riviere AS, Tisserand M, Boudour A, Bracard S. Posterior reversible encephalopathy syndrome: a case of unusual diffusion-weighted MR images. J Neuroradiol. 2009;36:102–5.PubMedCrossRef

30.

Schneider JP, Krohmer S, Gunther A, Zimmer C. [Cerebral lesions in acute arterial hypertension: the characteristic MRI in hypertensive encephalopathy]. Rofo. 2006;178:618–26.PubMedCrossRef

31.

Provenzale JM, Petrella JR, Cruz LC Jr, Wong JC, Engelter S, Barboriak DP. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2001;22:1455–61.PubMed

32.

Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008;29:447–55.PubMedCrossRef

33.

Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043–9.PubMedCrossRef

34.

McKinney AM, Sarikaya B, Gustafson C, Truwit CL. Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. AJNR Am J Neuroradiol. 2012;33:896–903.PubMedCrossRef

35.

Ugurel MS, Hayakawa M. Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome. Eur J Radiol. 2005;53:441–9.PubMedCrossRef

36.

Iwama M, Takahashi H, Takagi R, Hiraoka M. Permanent bilateral cortical blindness due to reversible posterior leukoencephalopathy syndrome. J Nippon Med Sch. 2011;78:184–8.PubMedCrossRef

37.

Pande AR, Ando K, Ishikura R, Nagami Y, Takada Y, Wada A, Watanabe Y, Miki Y, Uchino A, Nakao N. Clinicoradiological factors influencing the reversibility of posterior reversible encephalopathy syndrome: a multicenter study. Radiat Med. 2006;24:659–68.PubMedCrossRef

38.

Ulrich K, Troscher-Weber R, Tomandl BF, Neundorfer B, Reinhardt F. Posterior reversible encephalopathy in eclampsia: diffusion-weighted imaging and apparent diffusion coefficient-mapping as prognostic tools? Eur J Neurol. 2006;13:309–10.PubMedCrossRef

39.

Yilmaz S, Gokben S, Arikan C, Calli C, Serdaroglu G. Reversibility of cytotoxic edema in tacrolimus leukoencephalopathy. Pediatr Neurol. 2010;43:359–62.PubMedCrossRef

Title: Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns
Authors: O. Kastrup, MD, PhD
M. Schlamann, MD, PhD
C. Moenninghoff, MD
M. Forsting
S. Goericke, MD
Publication date: 01-06-2015
Publisher: Springer Berlin Heidelberg
Published in: Clinical Neuroradiology / Issue 2/2015
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI: https://doi.org/10.1007/s00062-014-0293-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns

Abstract

Aim

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aim

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2015

Cavernous Sinus: A Comprehensive Review of its Anatomy, Pathologic Conditions, and Imaging Features

Evaluation of Oral Anticoagulant-Associated Intracranial Parenchymal Hematomas Using CT Findings

ALK Positive Anaplastic Large Cell Lymphoma With Pure Leptomeningeal Involvement: Unique Case Report and Review of the Literature

Prevalence of Temporal Bone Fractures in Patients with Mandibular Fractures Using Multidetector-Row CT

Editorial

Quantitative Measurements of Cerebral Circulation in Spontaneously Regressing Traumatic Carotid-Cavernous Sinus Fistula with Velocity-Encoded Magnetic Resonance Imaging